Technologies related to Infectious diseases

Use of Detector Response Curves to Optimize Settings for Mass Spectrometry
Ref: E-157-2013-0 | Updated: Jan 20, 2014
A Simple Colorimetric Assay for Anti-malarial Drugs Quality Assurance and Rapid, On-site Counterfeit Detection
Ref: E-161-2013-0 | Updated: Jan 20, 2014
Sensitive Method for Detection and Quantification of Anthrax, Bordetella pertussis, Clostridium difficile, Clostridium botulinum and Other Pathogen-Derived Toxins in Human and Animal Plasma
Ref: E-167-2013-0 | Updated: Mar 3, 2017
Non-radioactive, Miniature Bipolar Aerosol Particle Charger for Personal, Portable Instrumentation
Ref: E-146-2013-0 | Updated: Jan 20, 2014
Rapid Detection of Antiretroviral(s) Drug-Resistant HIV-1 within Clinical Samples
Ref: E-129-2013-0 | Updated: Jan 20, 2014
Multiplexed Immunoassay for Rapid Serological Diagnosis of a Specific Viral Infection in Clinical Samples
Ref: E-302-2013-0 | Updated: Jan 17, 2014
Entangling/Entrapping Synthetic Setae for Control of Insects and Other Pests
Ref: E-175-2013-0 | Updated: Feb 21, 2014
Recombinant Stabilized Prefusion Protein of Respiratory Syncytial Virus for Use as a Subunit Vaccine
Ref: E-081-2013-0 | Updated: Jun 22, 2018
Real-time RT-PCR Assay for the Detection of Rift Valley Fever Virus in Humans and Livestock
Ref: E-187-2013-0 | Updated: Jan 16, 2014
Controlled Expression and Assembly of Human Group-C Rotavirus-like Particles for Creation of Rotavirus Diagnostic Assays and Improved Vaccine Formulations
Ref: E-191-2013-2 | Updated: Dec 26, 2019
Respiratory Syncytial Virus Immunogens for Vaccine and Therapeutics Development
Ref: E-197-2013-0 | Updated: Jan 16, 2014
Universal Diagnostic Assay for Detection and Identification of Poxviruses in Clinical Samples
Ref: E-265-2013-0 | Updated: Jan 16, 2014
Real-time PCR and High Resolution Melt Analysis for Genotyping of Chlamydophila psittaci
Ref: E-266-2013-0 | Updated: Jan 23, 2014
Novel Primate T-cell Lymphotropic Viruses (HTLV, STLV) for Development of Diagnostics, Therapeutics, Research Tools, and Vaccines
Ref: E-281-2013-0 | Updated: May 24, 2016
Detection and Differentiation of Pathogenic Fungi in Clinical Samples Using a Multi-Analyte Profiling System
Ref: E-293-2013-0 | Updated: Jan 23, 2014
Personal Air Sampler for Collecting Airborne Aerosol Particulates for Molecular Analysis by Size
Ref: E-244-2013-0 | Updated: May 25, 2016
Bispecific Antibodies to Target Latent HIV-1 Infection
Ref: E-071-2012-0 | Updated: Jan 6, 2014
Nucleic Acid-based Compositions and Methods for the Species-Specific Detection of Pathogenic Candida Fungi
Ref: E-340-2013-0 | Updated: Dec 23, 2013
Improved Protein Quantification Process and Vaccine Quality Control Production
Ref: E-212-2013-0 | Updated: Dec 23, 2013
Species-specific Nucleic Acid Detection Assay for Fungi
Ref: E-232-2013-0 | Updated: Dec 23, 2013
Nucleic Acid Detection of the Fungal Pathogen Histoplasma capsulatum from Clinical and Environmental Samples
Ref: E-313-2013-0 | Updated: May 7, 2018
Nucleic Acid Assays for the Detection and Discrimination of Aspergillus Fungi Species within Biological Samples
Ref: E-335-2013-0 | Updated: May 7, 2018
Novel Epitopes of Bacillus anthracis Lethal Factor for Development of Diagnostics and Therapeutics
Ref: E-210-2013-0 | Updated: Mar 3, 2017
Human Rotavirus Strains and Vaccines for Neonatal Childhood Protection
Ref: E-150-2013-0 | Updated: Dec 26, 2019
Novel Rift Valley Fever Virus Vaccines
Ref: E-254-2013-2 | Updated: Dec 23, 2013
Nucleic Acid-based Differentiation and Identification of Medically Important Fungi
Ref: E-332-2013-0 | Updated: Dec 23, 2013
Nucleic Acid-based Compositions and Methods for the Detection of Pathogenic Candida or Aspergillus Fungi Species
Ref: E-339-2013-0 | Updated: Dec 23, 2013
Use of Antisense Oligodeoxynucleotides for Inhibiting JC Virus
Ref: E-547-2013-0 | Updated: Feb 11, 2016
Intranasal Dry Powder Inhaler for Improved Delivery of Vaccines and Therapeutics
Ref: E-258-2013-0 | Updated: Dec 4, 2013
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013-0 | Updated: Jun 14, 2018
Diagnostics, Vaccines, and Delivery-Vehicles Related to Novel Phlebovirus
Ref: E-269-2013-0 | Updated: Dec 4, 2013
Human Influenza Virus Real-time RT-PCR Detection and Characterization Panel
Ref: E-331-2013-0 | Updated: Dec 4, 2013
Recombinant NIE Antigen from Strongyloides stercoralis
Ref: E-081-2012-0 | Updated: Nov 13, 2013
Peptide Vaccines Against Group A Streptococci
Ref: E-330-2013-0 | Updated: Oct 23, 2013
Novel Targets to Prevent Borrelia burgdorferi Infection and Lyme Disease
Ref: E-573-2013-0 | Updated: Feb 10, 2014
HIV-1 Multi-Clade, Multivalent Recombinant Vaccine Construct
Ref: E-231-2013-0 | Updated: Oct 23, 2013
T24 Antigen for Diagnosing or Treating Taenia solium Cysticercosis
Ref: E-237-2013-0 | Updated: Oct 23, 2013
Real-Time PCR Assay for Specific Detection of Haemophilus influenzae Serotypes A and B
Ref: E-164-2013-0 | Updated: Jan 16, 2014
Real-time RT-PCR Assay For Detection and Quantification of Hepatitis D Virus Infection
Ref: E-510-2013-0 | Updated: May 22, 2014
Diagnostic Assays Utilizing Real-Time Taqman or Seminested RT-PCR for Parechovirus Detection and Discrimination
Ref: E-295-2013-0 | Updated: Sep 19, 2013
Novel Recombinant Rabies Vaccine Also Capable of Immunocontraception
Ref: E-298-2013-0 | Updated: Sep 19, 2013
Real-time PCR Multiplex Assay for Detection of Bacterial Respiratory Pathogens in Clinical Specimens
Ref: E-300-2013-0 | Updated: Sep 19, 2013
Novel Live-Attenuated Rabies Vaccine
Ref: E-326-2013-0 | Updated: Nov 15, 2013
Method of Enhancing Opsonophagocytosis
Ref: E-329-2013-0 | Updated: May 7, 2018
Multiplex Real-time PCR Assay for Detection of Numerous Bacterial Pathogens
Ref: E-276-2013-0 | Updated: Sep 18, 2013
Methods of Detecting and Identifying Both Known and Novel Influenza Viruses
Ref: E-274-2013-0 | Updated: Sep 18, 2013
sodC-Based Real-Time PCR Assay for Detection of Neisseria meningitidis Infection
Ref: E-165-2013-0 | Updated: Sep 17, 2013
Isolated Lyssavirus Nucleic Acid and Protein Sequences
Ref: E-179-2013-0 | Updated: Sep 17, 2013
Antigen-capture Electrochemiluminescent Assay for Determining Rabies Vaccine Potency
Ref: E-180-2013-0 | Updated: Sep 17, 2013
Real-time PCR Assays for Selective Detection and Differentiation of B. pertussis, B. parapertussis and B. homesii
Ref: E-193-2013-0 | Updated: Sep 17, 2013
Recombinant Pan-Lyssavirus for Use in Rabies and Broad-Lyssavirus Vaccination
Ref: E-256-2013-0 | Updated: Sep 17, 2013
Real-time PCR Assay for Detection of Pneumococcal DNA and Diagnosis of Pneumococcal Disease
Ref: E-250-2013-0 | Updated: Jan 21, 2014
Linear Epitopes of Anthrax Toxin Protective Antigen for Development of a Peptide Vaccine
Ref: E-158-2013-2 | Updated: Jan 14, 2016
Composition and Methods for Rapid Detection of HIV by Loop-mediated Isothermal Amplification
Ref: E-173-2013-0 | Updated: Nov 20, 2013
Reduced Virulence Crimean-Congo Hemorrhagic Fever Virus for Vaccine Development
Ref: E-486-2013-0 | Updated: Aug 23, 2013
Monoclonal Antibodies That Recognize the Human Type I Interferon Receptor and Block Interferon Signaling
Ref: E-527-2013-0 | Updated: Aug 22, 2013
Rapid Detection of Multi-Drug-Resistant Mycobacterium tuberculosis Using Real-Time PCR and High-Resolution Melt Analysis
Ref: E-160-2013-0 | Updated: Dec 5, 2013
Real-time TaqMan RT-PCR Assays for Selective Detection of Human Rhinovirus
Ref: E-177-2013-0 | Updated: Aug 13, 2013
Real-Time PCR for Detecting Legionella Species and Discriminating Legionella pneumophila
Ref: E-194-2013-0 | Updated: Sep 19, 2013
Use of Vitronectin as a Biomarker for the Detection of Dengue Hemorrhagic Fever
Ref: E-147-2013-0 | Updated: Aug 13, 2013
Simultaneous Detection of Non-pneumophila Legionella Strains Using Real-time PCR
Ref: E-277-2013-0 | Updated: Aug 2, 2013
Real-Time RT-PCR Assay for Detection of Noroviruses
Ref: E-145-2013-0 | Updated: Aug 2, 2013
Multiplex Assay for Detection of Dengue Virus
Ref: E-148-2013-0 | Updated: Oct 18, 2013
Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection
Ref: E-217-2004-0 | Updated: Jul 9, 2013
Live Attenuated RSV Vaccines Based on Codon-Pair Deoptimization
Ref: E-080-2013-0 | Updated: Jun 6, 2013
Parvovirus B19 Vaccine
Ref: E-286-1988-1 | Updated: May 7, 2013
Modified Peptide Nucleic Acids (PNAs) for Detection of DNA or RNA and Identification of a Disease or Pathogen
Ref: E-260-2012-0 | Updated: Mar 16, 2017
Novel Vaccine for Prevention and Treatment of Chlamydia Infection
Ref: E-133-2012-0 | Updated: Aug 11, 2015
Transmission-Blocking Malaria Vaccine
Ref: E-222-2012-0 | Updated: May 16, 2018
Methods and Composition for Identification of Variants of JC Virus DNA; An Etiologic Agent for Progressive Multifocal Leukoencephalopathy (PML)
Ref: E-088-2012-0 | Updated: Jan 11, 2013
Antimalarial Inhibitors that Target the Plasmodial Surface Anion Channel (PSAC) Protein and Development of the PSAC Protein as Vaccine Targets
Ref: E-145-2011-0 | Updated: Jan 5, 2021
Salen-Manganese Compounds for Therapy of Viral Infections
Ref: E-281-2011-0 | Updated: Apr 11, 2016
Mouse Model of STAT5 for the Drug Screen and the Research of Cancer and Autoimmunity
Ref: E-080-2011-0 | Updated: Jun 13, 2012
Treatment of Viral Infection by Blocking Interleukin-21
Ref: E-017-2012-0 | Updated: Jun 6, 2012
Human DNA Polymerase Gamma for Testing the Effect of Drugs on Mitochondrial Function
Ref: B-035-1998-0 | Updated: May 7, 2018
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011-0 | Updated: Jun 18, 2014
Treatment of Tuberculosis — Adjuvant Therapies to Increase the Efficiency of Antibiotics
Ref: E-189-2011-0 | Updated: May 7, 2018
Protease Deficient Bacillus anthracis with Improved Recombinant Protein Yield Capabilities
Ref: E-202-2011-0 | Updated: Feb 25, 2015
Rapid Molecular Assays for Specific Detection and Quantitation of Loa Loa Microfilaremia
Ref: E-014-2011-0 | Updated: May 3, 2016
Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)
Ref: E-231-2011-0 | Updated: Sep 29, 2011
Diagnostic Assays and Methods of Use for Detection of Filarial Infection
Ref: E-281-2010-0 | Updated: May 6, 2018
Transgenic Mice Expressing Human Arginase II Gene in Endothelium: Useful for Studying Atherosclerosis and Other Vasculopathies
Ref: E-255-2010-0 | Updated: Aug 30, 2011
Monoclonal Antibodies Against Poliovirus
Ref: E-076-2011-0 | Updated: Mar 9, 2015
Methods of Treating Giardiasis Using FDA-Approved Compounds
Ref: E-211-2010-1 | Updated: Aug 17, 2012
Multivalent Vaccines for Rabies Virus and Filoviruses
Ref: E-032-2011-0 | Updated: May 7, 2018
Improved Standard for Immune System Recovery Assay
Ref: E-067-2011-0 | Updated: Nov 3, 2017
New Molecules for HIV Therapeutics: Fab, scFv, and Related Binding Molecules Specific for HIV-1 Rev
Ref: E-064-2011-0 | Updated: May 9, 2018
Novel Therapeutic Compounds for Treatment of Cancer and Immune Disorders
Ref: E-291-2009-0 | Updated: Nov 26, 2010
Prevention and Treatment of Herpes Virus Infection by Inhibition of the JMJD2 Family of Histone Demethylases
Ref: E-184-2010-0 | Updated: Mar 18, 2015
Full-Length Infectious cDNA Clones of Tick Borne Flavivirus
Ref: E-281-1998-0 | Updated: Sep 28, 2010
Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation
Ref: E-055-2009-0 | Updated: Sep 21, 2015
Novel Antigen for Use as Vaccine Against Nematode Infection
Ref: E-084-2010-0 | Updated: Jul 12, 2010
Simple, Quantitative Sensitive High-throughput Antibody Detection for Lyme Disease
Ref: E-036-2010-1 | Updated: May 8, 2018
Parvovirus B19 Codon Optimized Structural Proteins for Vaccine and Diagnostic Applications
Ref: E-011-2010-0 | Updated: Apr 30, 2012
Erythroid Progenitor Cell Line for Hematological Disease Applications
Ref: E-151-2010-0 | Updated: Feb 28, 2011
Moraxella Catarrhalis Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections
Ref: E-264-1997-0 | Updated: Jul 1, 2014
Defensin-Based Therapeutics for the Treatment of Pulmonary Disease
Ref: E-243-2009-0 | Updated: Jun 14, 2010
HIV-1 Infection Detection Assay for Seroconverted HIV-1 Vaccine Recipients
Ref: E-259-2004-2 | Updated: Jul 31, 2012
Vaccines Against Malarial Diseases
Ref: E-052-2004-0 | Updated: Feb 28, 2011
A Novel Multimeric CD4 Fusion Protein for Treating HIV Infection
Ref: E-337-2001-0 | Updated: Jun 14, 2010


Subscribe to Technologies related to Infectious diseases